AAAAAA
Results:
1-7
|
Results: 7
Authors:
ANTONIN KH
RAK R
BIECK PR
PREISS R
SCHENKER U
HASTEWELL J
FOX R
MACKAY M
Citation: Kh. Antonin et al., THE ABSORPTION OF HUMAN CALCITONIN FROM THE TRANSVERSE COLON OF MAN, International journal of pharmaceutics, 130(1), 1996, pp. 33-39
Authors:
REIMANN IW
JOBERT M
GLEITER CH
TURRI M
BIECK PR
HERRMANN WM
Citation: Iw. Reimann et al., DIFFERENT MODES OF DATA-PROCESSING AND STATISTICAL TESTING APPLIED TOTHE SAME SET OF PHARMACO-EEG RECORDINGS - EFFECTS ON THE EVALUATION OF A SELECTIVE AND THE REVERSIBLE MAO-A-INHIBITOR (BROFAROMINE), Neuropsychobiology, 33(3), 1996, pp. 160-163
Authors:
GLEITER CH
MUHLBAUER B
SCHULZ RM
NILSSON E
ANTONIN KH
BIECK PR
Citation: Ch. Gleiter et al., MONOAMINE-OXIDASE INHIBITION BY THE MAO-A INHIBITORS BROFAROMINE AND CLORGYLINE IN HEALTHY-VOLUNTEERS, Journal of neural transmission, 95(3), 1994, pp. 241-245
METABOLISM OF THE NEW MAO-A INHIBITOR BROFAROMINE IN POOR AND EXTENSIVE METABOLIZERS OF DEBRISOQUINE
Authors:
JEDRYCHOWSKI M
FEIFEL N
BIECK PR
SCHMIDT EK
Citation: M. Jedrychowski et al., METABOLISM OF THE NEW MAO-A INHIBITOR BROFAROMINE IN POOR AND EXTENSIVE METABOLIZERS OF DEBRISOQUINE, Journal of pharmaceutical and biomedical analysis, 11(3), 1993, pp. 251-255
Authors:
BIECK PR
ANTONIN KH
FARGER G
NILSSON EB
SCHMIDT EK
DOSTERT P
BENEDETTI MS
WALDMEIER PC
Citation: Pr. Bieck et al., CLINICAL-PHARMACOLOGY OF THE NEW COMT INHIBITOR CGP-28014, Neurochemical research, 18(11), 1993, pp. 1163-1167
Authors:
BIECK PR
ANTONIN KH
SCHMIDT E
Citation: Pr. Bieck et al., CLINICAL-PHARMACOLOGY OF REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS, Clinical neuropharmacology, 16, 1993, pp. 190000034-190000041
Authors:
FEIFEL N
KUCHER K
FUCHS L
JEDRYCHOWSKI M
SCHMIDT E
ANTONIN KH
BIECK PR
GLEITER CH
Citation: N. Feifel et al., ROLE OF CYTOCHROME-P4502D6 IN THE METABOLISM OF BROFAROMINE - A NEW SELECTIVE MAO-A INHIBITOR, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 265-269
Risultati:
1-7
|